ONZETRA XSAIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Onzetra Xsail, and what generic alternatives are available?
Onzetra Xsail is a drug marketed by Currax and is included in one NDA. There are sixteen patents protecting this drug.
This drug has two hundred and sixty-six patent family members in twenty-nine countries.
The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Onzetra Xsail
A generic version of ONZETRA XSAIL was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ONZETRA XSAIL?
- What are the global sales for ONZETRA XSAIL?
- What is Average Wholesale Price for ONZETRA XSAIL?
Summary for ONZETRA XSAIL
International Patents: | 266 |
US Patents: | 16 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Clinical Trials: | 1 |
Patent Applications: | 2,223 |
Drug Prices: | Drug price information for ONZETRA XSAIL |
What excipients (inactive ingredients) are in ONZETRA XSAIL? | ONZETRA XSAIL excipients list |
DailyMed Link: | ONZETRA XSAIL at DailyMed |
Recent Clinical Trials for ONZETRA XSAIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Avanir Pharmaceuticals | Phase 3 |
Currax Pharmaceuticals | Phase 3 |
Pharmacology for ONZETRA XSAIL
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
US Patents and Regulatory Information for ONZETRA XSAIL
ONZETRA XSAIL is protected by twenty-two US patents.
Patents protecting ONZETRA XSAIL
Nasal delivery devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Nasal delivery devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY
Nasal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Nasal devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal delivery devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Nasal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Powder delivery devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal delivery devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal delivery device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nasal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE
Nasal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Nasal administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ONZETRA XSAIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ONZETRA XSAIL
See the table below for patents covering ONZETRA XSAIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 20014182 | ⤷ Sign Up | |
Austria | 427130 | ⤷ Sign Up | |
United Kingdom | 0005254 | ⤷ Sign Up | |
Canada | 2953606 | ⤷ Sign Up | |
European Patent Office | 2570146 | ⤷ Sign Up | |
European Patent Office | 3124067 | ⤷ Sign Up | |
Cyprus | 1111201 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |